Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study

por Johansson, S, Apajasalo, M, Sarapohja, T, Garratt, C
Publicado 2004

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study

por Garratt, C, Packer, M, Colucci, W, Fisher, L, Massie, B, Teerlink, J, Young, J
Publicado 2004

A multinational, drug utilisation study to investigate the use of dexmedetomidine (DEXDOR®) in clinical practice in the EU

por Garratt, C, Weatherall, M, Pohjanjousi, P, Aantao, R, Conti, G, Lewis, M, Moore, N, Perez-Gutthann, S
Publicado 2015

Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients

por Iirola, T, Aantaa, R, Laitio, R, Kentala, E, Lahtinen, M, Wighton, A, Garratt, C, Ahtola-Sätilä, T, Olkkola, KT
Publicado 2011